-
1
-
-
84902672359
-
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
-
Yki-Järvinen, H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2, 901-910 (2014).
-
(2014)
Lancet Diabetes Endocrinol.
, vol.2
, pp. 901-910
-
-
Yki-Järvinen, H.1
-
2
-
-
79960299426
-
Non-alcoholic fatty liver disease: What's new under the microscope?
-
Brunt, E. M. Non-alcoholic fatty liver disease: what's new under the microscope? Gut 60, 1152-1158 (2011).
-
(2011)
Gut
, vol.60
, pp. 1152-1158
-
-
Brunt, E.M.1
-
3
-
-
84928215996
-
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis
-
Torres, D. M. & Harrison, S. A. Nonalcoholic fatty liver disease: fibrosis portends a worse prognosis. Hepatology 61, 1462-1464 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 1462-1464
-
-
Torres, D.M.1
Harrison, S.A.2
-
4
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113-121 (2005).
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
-
5
-
-
84928209634
-
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
-
Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547-1554 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 1547-1554
-
-
Ekstedt, M.1
-
6
-
-
84861197159
-
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
-
Baffy, G., Brunt, E. M. & Caldwell, S. H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J. Hepatol. 56, 1384-1391 (2012).
-
(2012)
J. Hepatol.
, vol.56
, pp. 1384-1391
-
-
Baffy, G.1
Brunt, E.M.2
Caldwell, S.H.3
-
7
-
-
84938057875
-
Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease
-
Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389-397 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 389-397
-
-
Angulo, P.1
-
8
-
-
79954498879
-
Inflammation in nonalcoholic steatohepatitis
-
Harmon, R. C., Tiniakos, D. G. & Argo, C. K. Inflammation in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5, 189-200 (2011).
-
(2011)
Expert Rev. Gastroenterol. Hepatol.
, vol.5
, pp. 189-200
-
-
Harmon, R.C.1
Tiniakos, D.G.2
Argo, C.K.3
-
9
-
-
84930788424
-
Nonalcoholic fatty liver disease
-
Rinella, M. E. Nonalcoholic fatty liver disease. JAMA 313, 2263-2273 (2015).
-
(2015)
JAMA
, vol.313
, pp. 2263-2273
-
-
Rinella, M.E.1
-
10
-
-
7844224387
-
Liver and biliary ultrasonography in diabetic and non-diabetic obese women
-
Araújo, L. M., De Oliveira, D. A. & Nunes, D. S. Liver and biliary ultrasonography in diabetic and non-diabetic obese women. Diabetes Metab. 24, 458-462 (1998).
-
(1998)
Diabetes Metab.
, vol.24
, pp. 458-462
-
-
Araújo, L.M.1
De Oliveira, D.A.2
Nunes, D.S.3
-
11
-
-
21344449292
-
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
-
Bedogni, G. et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44-52 (2005).
-
(2005)
Hepatology
, vol.42
, pp. 44-52
-
-
Bedogni, G.1
-
12
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
-
Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124-131 (2011).
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
-
13
-
-
33746700131
-
Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures
-
Zelber-Sagi, S., Nitzan-Kaluski, D., Halpern, Z. & Oren, R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 26, 856-863 (2006).
-
(2006)
Liver Int.
, vol.26
, pp. 856-863
-
-
Zelber-Sagi, S.1
Nitzan-Kaluski, D.2
Halpern, Z.3
Oren, R.4
-
14
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
-
Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395 (2004).
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
-
15
-
-
34247605492
-
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
-
Targher, G. et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30, 1212-1218 (2007).
-
(2007)
Diabetes Care
, vol.30
, pp. 1212-1218
-
-
Targher, G.1
-
16
-
-
0025260531
-
Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
-
Wanless, I. R. & Lentz, J. S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12, 1106-1110 (1990).
-
(1990)
Hepatology
, vol.12
, pp. 1106-1110
-
-
Wanless, I.R.1
Lentz, J.S.2
-
17
-
-
0025002079
-
Liver pathology in morbidly obese patients with and without diabetes
-
Silverman, J. F. et al. Liver pathology in morbidly obese patients with and without diabetes. Am. J. Gastroenterol. 85, 1349-1355 (1990).
-
(1990)
Am. J. Gastroenterol.
, vol.85
, pp. 1349-1355
-
-
Silverman, J.F.1
-
18
-
-
0033038672
-
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
-
Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419 (1999).
-
(1999)
Gastroenterology
, vol.116
, pp. 1413-1419
-
-
Matteoni, C.A.1
-
19
-
-
0034950652
-
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
-
Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121, 91-100 (2001).
-
(2001)
Gastroenterology
, vol.121
, pp. 91-100
-
-
Dixon, J.B.1
Bhathal, P.S.2
O'Brien, P.E.3
-
20
-
-
84896396831
-
A population-based study on the prevalence of NASH using scores validated against liver histology
-
Hyysalo, J. et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J. Hepatol. 60, 839-846 (2014).
-
(2014)
J. Hepatol.
, vol.60
, pp. 839-846
-
-
Hyysalo, J.1
-
21
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
Ascha, M. S. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51, 1972-1978 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
-
22
-
-
84923893879
-
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
-
Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547-555 (2015).
-
(2015)
Gastroenterology
, vol.148
, pp. 547-555
-
-
Wong, R.J.1
-
23
-
-
84880417614
-
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
-
Fan, J.-G. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J. Gastroenterol. Hepatol. 28 (Suppl. 1), 11-17 (2013).
-
(2013)
J. Gastroenterol. Hepatol.
, vol.28
, pp. 11-17
-
-
Fan, J.-G.1
-
24
-
-
0344393668
-
Increase in the prevalence of fatty liver in Japan over the past 12 years: Analysis of clinical background
-
Kojima, S.-I., Watanabe, N., Numata, M., Ogawa, T. & Matsuzaki, S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 38, 954-961 (2003).
-
(2003)
J. Gastroenterol.
, vol.38
, pp. 954-961
-
-
Kojima, S.-I.1
Watanabe, N.2
Numata, M.3
Ogawa, T.4
Matsuzaki, S.5
-
25
-
-
84918504185
-
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
-
Wong, V. W.-S. et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J. Hepatol. 62, 182-189 (2015).
-
(2015)
J. Hepatol.
, vol.62
, pp. 182-189
-
-
Wong, V.W.-S.1
-
26
-
-
84857046691
-
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography
-
Wong, V. W.-S. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61, 409-415 (2012).
-
(2012)
Gut
, vol.61
, pp. 409-415
-
-
Wong, V.W.-S.1
-
27
-
-
84874645372
-
Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010
-
Welsh, J. A., Karpen, S. & Vos, M. B. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J. Pediatr. 162, 496-500 (2013).
-
(2013)
J. Pediatr.
, vol.162
, pp. 496-500
-
-
Welsh, J.A.1
Karpen, S.2
Vos, M.B.3
-
28
-
-
84930677627
-
Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages
-
Mangge, H. et al. Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages. Aliment. Pharmacol. Ther. 42, 99-105 (2015).
-
(2015)
Aliment. Pharmacol. Ther.
, vol.42
, pp. 99-105
-
-
Mangge, H.1
-
29
-
-
84964310794
-
Nonalcoholic fatty liver disease
-
Nobili, V. et al. Nonalcoholic fatty liver disease. JAMA Pediatr. 169, 170-176 (2015).
-
(2015)
JAMA Pediatr.
, vol.169
, pp. 170-176
-
-
Nobili, V.1
-
30
-
-
33750002388
-
Prevalence of fatty liver in children and adolescents
-
Schwimmer, J. B. et al. Prevalence of fatty liver in children and adolescents. Pediatrics 118, 1388-1393 (2006).
-
(2006)
Pediatrics
, vol.118
, pp. 1388-1393
-
-
Schwimmer, J.B.1
-
31
-
-
51549116759
-
The obesity epidemic and nonalcoholic fatty liver disease in children
-
Dunn, W. & Schwimmer, J. B. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr. Gastroenterol. Rep. 10, 67-72 (2008).
-
(2008)
Curr. Gastroenterol. Rep.
, vol.10
, pp. 67-72
-
-
Dunn, W.1
Schwimmer, J.B.2
-
32
-
-
65249188812
-
Heritability of nonalcoholic fatty liver disease
-
Schwimmer, J. B. et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 136, 1585-1592 (2009).
-
(2009)
Gastroenterology
, vol.136
, pp. 1585-1592
-
-
Schwimmer, J.B.1
-
33
-
-
84951727954
-
Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children
-
Yang, H. R., Yi, D. Y. & Choi, H. S. Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children. J. Korean Med. Sci. 29, 1672-1677 (2014).
-
(2014)
J. Korean Med. Sci.
, vol.29
, pp. 1672-1677
-
-
Yang, H.R.1
Yi, D.Y.2
Choi, H.S.3
-
35
-
-
6044227998
-
Hepatic steatosis in obese Chinese children
-
Chan, D. F. Y. et al. Hepatic steatosis in obese Chinese children. Int. J. Obes. Relat. Metab. Disord. 28, 1257-1263 (2004).
-
(2004)
Int. J. Obes. Relat. Metab. Disord.
, vol.28
, pp. 1257-1263
-
-
Chan, D.F.Y.1
-
36
-
-
58149085720
-
The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents
-
Booth, M. L. et al. The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents. J. Paediatr. Child Health 44, 686-691 (2008).
-
(2008)
J. Paediatr. Child Health
, vol.44
, pp. 686-691
-
-
Booth, M.L.1
-
37
-
-
49649094683
-
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis
-
Maher, J. J., Leon, P. & Ryan, J. C. Beyond insulin resistance: innate immunity in nonalcoholic steatohepatitis. Hepatology 48, 670-678 (2008).
-
(2008)
Hepatology
, vol.48
, pp. 670-678
-
-
Maher, J.J.1
Leon, P.2
Ryan, J.C.3
-
38
-
-
80053450975
-
The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
-
He, J., Lee, J. H., Febbraio, M. & Xie, W. The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease. Exp. Biol. Med. (Maywood) 236, 1116-1121 (2011).
-
(2011)
Exp. Biol. Med. (Maywood)
, vol.236
, pp. 1116-1121
-
-
He, J.1
Lee, J.H.2
Febbraio, M.3
Xie, W.4
-
39
-
-
63649104470
-
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
-
Mitsuyoshi, H. et al. Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol. Res. 39, 366-373 (2009).
-
(2009)
Hepatol. Res.
, vol.39
, pp. 366-373
-
-
Mitsuyoshi, H.1
-
40
-
-
33847404482
-
Inhibition of protein kinase Cϵ prevents hepatic insulin resistance in nonalcoholic fatty liver disease
-
Samuel, V. T. et al. Inhibition of protein kinase Cϵ prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117, 739-745 (2007).
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 739-745
-
-
Samuel, V.T.1
-
41
-
-
40549135297
-
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice
-
Postic, C. & Girard, J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118, 829-838 (2008).
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 829-838
-
-
Postic, C.1
Girard, J.2
-
42
-
-
84894327806
-
Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease
-
Lambert, J. E., Ramos-Roman, M. A., Browning, J. D. & Parks, E. J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726-735 (2014).
-
(2014)
Gastroenterology
, vol.146
, pp. 726-735
-
-
Lambert, J.E.1
Ramos-Roman, M.A.2
Browning, J.D.3
Parks, E.J.4
-
43
-
-
18244382304
-
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
-
Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351 (2005).
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 1343-1351
-
-
Donnelly, K.L.1
-
44
-
-
77649264504
-
Bifurcation of insulin signaling pathway in rat liver: MTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
-
Li, S., Brown, M. S. & Goldstein, J. L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl Acad. Sci. USA 107, 3441-3446 (2010).
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 3441-3446
-
-
Li, S.1
Brown, M.S.2
Goldstein, J.L.3
-
45
-
-
66449137379
-
GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice
-
Kammoun, H. L. et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215 (2009).
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 1201-1215
-
-
Kammoun, H.L.1
-
46
-
-
80053618114
-
Linking long-term dietary patterns with gut microbial enterotypes
-
Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105-108 (2011).
-
(2011)
Science
, vol.334
, pp. 105-108
-
-
Wu, G.D.1
-
47
-
-
84898824175
-
Interactions between the intestinal microbiome and liver diseases
-
Schnabl, B. & Brenner, D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513-1524 (2014).
-
(2014)
Gastroenterology
, vol.146
, pp. 1513-1524
-
-
Schnabl, B.1
Brenner, D.A.2
-
48
-
-
84937738375
-
Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis
-
Koliaki, C. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21, 739-746 (2015).
-
(2015)
Cell Metab.
, vol.21
, pp. 739-746
-
-
Koliaki, C.1
-
49
-
-
84884984539
-
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
-
Begriche, K., Massart, J., Robin, M.-A., Bonnet, F. & Fromenty, B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 58, 1497-1507 (2013).
-
(2013)
Hepatology
, vol.58
, pp. 1497-1507
-
-
Begriche, K.1
Massart, J.2
Robin, M.-A.3
Bonnet, F.4
Fromenty, B.5
-
50
-
-
84919465499
-
Cell death and cell death responses in liver disease: Mechanisms and clinical relevance
-
Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765-783 (2014).
-
(2014)
Gastroenterology
, vol.147
, pp. 765-783
-
-
Luedde, T.1
Kaplowitz, N.2
Schwabe, R.F.3
-
51
-
-
44949233264
-
Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress
-
Upton, J.-P. et al. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol. Cell. Biol. 28, 3943-3951 (2008).
-
(2008)
Mol. Cell. Biol.
, vol.28
, pp. 3943-3951
-
-
Upton, J.-P.1
-
52
-
-
84877897842
-
Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis
-
Johnson, E. S. et al. Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. J. Biol. Chem. 288, 14463-14475 (2013).
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 14463-14475
-
-
Johnson, E.S.1
-
53
-
-
84933039083
-
Reduced lipoapoptosis, Hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis
-
Machado, M. V. et al. Reduced lipoapoptosis, Hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut 64, 1148-1157 (2015).
-
(2015)
Gut
, vol.64
, pp. 1148-1157
-
-
Machado, M.V.1
-
54
-
-
0042165989
-
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
-
Feldstein, A. E. et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125, 437-443 (2003).
-
(2003)
Gastroenterology
, vol.125
, pp. 437-443
-
-
Feldstein, A.E.1
-
55
-
-
80655149472
-
Death receptor 5 signaling promotes hepatocyte lipoapoptosis
-
Cazanave, S. C. et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J. Biol. Chem. 286, 39336-39348 (2011).
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 39336-39348
-
-
Cazanave, S.C.1
-
56
-
-
84905472344
-
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
-
Inokuchi-Shimizu, S. et al. TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. J. Clin. Invest. 124, 3566-3578 (2014).
-
(2014)
J. Clin. Invest.
, vol.124
, pp. 3566-3578
-
-
Inokuchi-Shimizu, S.1
-
57
-
-
84905239992
-
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
-
Gautheron, J. et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6, 1062-1074 (2014).
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 1062-1074
-
-
Gautheron, J.1
-
58
-
-
84910020145
-
Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
-
Wehr, A. et al. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. PLoS ONE 9, e112327 (2014).
-
(2014)
PLoS ONE
, vol.9
, pp. e112327
-
-
Wehr, A.1
-
59
-
-
77952730087
-
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
-
Syn, W.-K. et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 51, 1998-2007 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1998-2007
-
-
Syn, W.-K.1
-
60
-
-
84865041500
-
NKT-associated Hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
-
Syn, W.-K. et al. NKT-associated Hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61, 1323-1329 (2012).
-
(2012)
Gut
, vol.61
, pp. 1323-1329
-
-
Syn, W.-K.1
-
61
-
-
84899490742
-
IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
-
Harley, I. T. W. et al. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology 59, 1830-1839 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 1830-1839
-
-
Harley, I.T.W.1
-
62
-
-
84896722464
-
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
-
Sutti, S. et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59, 886-897 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 886-897
-
-
Sutti, S.1
-
63
-
-
84907976095
-
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes
-
Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549-564 (2014).
-
(2014)
Cancer Cell
, vol.26
, pp. 549-564
-
-
Wolf, M.J.1
-
64
-
-
84880425458
-
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
-
Roh, Y. S. & Seki, E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J. Gastroenterol. Hepatol. 28 (Suppl. 1), 38-42 (2013).
-
(2013)
J. Gastroenterol. Hepatol.
, vol.28
, pp. 38-42
-
-
Roh, Y.S.1
Seki, E.2
-
65
-
-
84904647950
-
The inflammasome in liver injury and non-alcoholic fatty liver disease
-
Mehal, W. Z. The inflammasome in liver injury and non-alcoholic fatty liver disease. Dig. Dis. 32, 507-515 (2014).
-
(2014)
Dig. Dis.
, vol.32
, pp. 507-515
-
-
Mehal, W.Z.1
-
66
-
-
84870042853
-
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production
-
Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I. & Hahn, Y. S. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J. Biol. Chem. 287, 40161-40172 (2012).
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 40161-40172
-
-
Tosello-Trampont, A.-C.1
Landes, S.G.2
Nguyen, V.3
Novobrantseva, T.I.4
Hahn, Y.S.5
-
67
-
-
84862669638
-
Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis
-
Leroux, A. et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J. Hepatol. 57, 141-149 (2012).
-
(2012)
J. Hepatol.
, vol.57
, pp. 141-149
-
-
Leroux, A.1
-
68
-
-
84929310290
-
Emerging and disease-specific mechanisms of hepatic stellate cell activation
-
Wallace, M. C., Friedman, S. L. & Mann, D. A. Emerging and disease-specific mechanisms of hepatic stellate cell activation. Semin. Liver Dis. 35, 107-118 (2015).
-
(2015)
Semin. Liver Dis.
, vol.35
, pp. 107-118
-
-
Wallace, M.C.1
Friedman, S.L.2
Mann, D.A.3
-
69
-
-
35948958955
-
TLR4 enhances TGF-β signaling and hepatic fibrosis
-
Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332 (2007).
-
(2007)
Nat. Med.
, vol.13
, pp. 1324-1332
-
-
Seki, E.1
-
70
-
-
84894875873
-
Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
-
Tomita, K. et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology 59, 154-169 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 154-169
-
-
Tomita, K.1
-
71
-
-
84884979408
-
Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice
-
Jiang, J. X. et al. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. Hepatology 58, 1339-1348 (2013).
-
(2013)
Hepatology
, vol.58
, pp. 1339-1348
-
-
Jiang, J.X.1
-
72
-
-
79958229659
-
Increased production of Sonic Hedgehog by ballooned hepatocytes
-
Rangwala, F. et al. Increased production of Sonic Hedgehog by ballooned hepatocytes. J. Pathol. 224, 401-410 (2011).
-
(2011)
J. Pathol.
, vol.224
, pp. 401-410
-
-
Rangwala, F.1
-
73
-
-
78651426961
-
The role of Hedgehog signaling in fibrogenic liver repair
-
Choi, S. S., Omenetti, A., Syn, W.-K. & Diehl, A. M. The role of Hedgehog signaling in fibrogenic liver repair. Int. J. Biochem. Cell Biol. 43, 238-244 (2011).
-
(2011)
Int. J. Biochem. Cell Biol.
, vol.43
, pp. 238-244
-
-
Choi, S.S.1
Omenetti, A.2
Syn, W.-K.3
Diehl, A.M.4
-
74
-
-
84880651918
-
Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis
-
Hirsova, P., Ibrahim, S. H., Bronk, S. F., Yagita, H. & Gores, G. J. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS ONE 8, e70599 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e70599
-
-
Hirsova, P.1
Ibrahim, S.H.2
Bronk, S.F.3
Yagita, H.4
Gores, G.J.5
-
75
-
-
84878930738
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
-
Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330-344 (2013).
-
(2013)
Nat. Rev. Gastroenterol. Hepatol.
, vol.10
, pp. 330-344
-
-
Anstee, Q.M.1
Targher, G.2
Day, C.P.3
-
76
-
-
84855978332
-
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
-
Al-Serri, A. et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J. Hepatol. 56, 448-454 (2012).
-
(2012)
J. Hepatol.
, vol.56
, pp. 448-454
-
-
Al-Serri, A.1
-
77
-
-
34047116836
-
The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population
-
Dong, H. et al. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J. Hepatol. 46, 915-920 (2007).
-
(2007)
J. Hepatol.
, vol.46
, pp. 915-920
-
-
Dong, H.1
-
78
-
-
84920951650
-
Fatty acid desaturase 1 gene polymorphisms control human hepatic lipid composition
-
Wang, L. et al. Fatty acid desaturase 1 gene polymorphisms control human hepatic lipid composition. Hepatology 61, 119-128 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 119-128
-
-
Wang, L.1
-
79
-
-
46049097550
-
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease
-
Miele, L. et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282-291 (2008).
-
(2008)
Gastroenterology
, vol.135
, pp. 282-291
-
-
Miele, L.1
-
80
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465 (2008).
-
(2008)
Nat. Genet.
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
-
81
-
-
78049457761
-
Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease
-
Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139, 1567-1576 (2010).
-
(2010)
Gastroenterology
, vol.139
, pp. 1567-1576
-
-
Chalasani, N.1
-
82
-
-
79953745343
-
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
-
Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
-
(2011)
PLoS Genet.
, vol.7
, pp. e1001324
-
-
Speliotes, E.K.1
-
83
-
-
84878934119
-
Genome-wide association analysis confirms importance of PNPLA3 and identifies novel variants associated with histologically progressive steatohepatitis in NAFLD
-
Anstee, Q. et al. Genome-wide association analysis confirms importance of PNPLA3 and identifies novel variants associated with histologically progressive steatohepatitis in NAFLD. Hepatology 56, 265A-266A (2012).
-
(2012)
Hepatology
, vol.56
, pp. 265A-266A
-
-
Anstee, Q.1
-
84
-
-
84862267335
-
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese
-
Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7, e38322 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e38322
-
-
Kawaguchi, T.1
-
85
-
-
84876785272
-
The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart study
-
Feitosa, M. F. et al. The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart study. Atherosclerosis 228, 175-180 (2013).
-
(2013)
Atherosclerosis
, vol.228
, pp. 175-180
-
-
Feitosa, M.F.1
-
86
-
-
84898058711
-
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
-
Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356 (2014).
-
(2014)
Nat. Genet.
, vol.46
, pp. 352-356
-
-
Kozlitina, J.1
-
87
-
-
84939949211
-
Genome-wide analysis of hepatic lipid content in extreme obesity
-
DiStefano, J. K. et al. Genome-wide analysis of hepatic lipid content in extreme obesity. Acta Diabetol. 52, 373-382 (2015).
-
(2015)
Acta Diabetol.
, vol.52
, pp. 373-382
-
-
DiStefano, J.K.1
-
88
-
-
77950607738
-
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
-
Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209-1217 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1209-1217
-
-
Valenti, L.1
-
89
-
-
84902688337
-
Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
-
Liu, Y.-L. et al. Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J. Hepatol. 61, 75-81 (2014).
-
(2014)
J. Hepatol.
, vol.61
, pp. 75-81
-
-
Liu, Y.-L.1
-
90
-
-
84920955177
-
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
-
Smagris, E. et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61, 108-118 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 108-118
-
-
Smagris, E.1
-
91
-
-
84903996547
-
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
-
Pirazzi, C. et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Hum. Mol. Genet. 23, 4077-4085 (2014).
-
(2014)
Hum. Mol. Genet.
, vol.23
, pp. 4077-4085
-
-
Pirazzi, C.1
-
92
-
-
84903708160
-
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
-
Liu, Y.-L. et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 4309 (2014).
-
(2014)
Nat. Commun.
, vol.5
, pp. 4309
-
-
Liu, Y.-L.1
-
93
-
-
84898058547
-
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
-
Holmen, O. L. et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345-351 (2014).
-
(2014)
Nat. Genet.
, vol.46
, pp. 345-351
-
-
Holmen, O.L.1
-
94
-
-
84925357379
-
TM6SF2: Catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?
-
Kahali, B. et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 148, 679-684 (2015).
-
(2015)
Gastroenterology
, vol.148
, pp. 679-684
-
-
Kahali, B.1
-
95
-
-
84921487729
-
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
-
Dongiovanni, P. et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 61, 506-514 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 506-514
-
-
Dongiovanni, P.1
-
96
-
-
79957462315
-
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
-
Sookoian, S. & Pirola, C. J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883-1894 (2011).
-
(2011)
Hepatology
, vol.53
, pp. 1883-1894
-
-
Sookoian, S.1
Pirola, C.J.2
-
97
-
-
84886772574
-
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease
-
Murphy, S. K. et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 145, 1076-1087 (2013).
-
(2013)
Gastroenterology
, vol.145
, pp. 1076-1087
-
-
Murphy, S.K.1
-
98
-
-
33846200332
-
Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: Implications for wound healing and fibrogenesis
-
Mann, J. et al. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 14, 275-285 (2007).
-
(2007)
Cell Death Differ.
, vol.14
, pp. 275-285
-
-
Mann, J.1
-
99
-
-
84942833417
-
Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease
-
Kitamoto, T. et al. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease. J. Hepatol. 63, 494-502 (2015).
-
(2015)
J. Hepatol.
, vol.63
, pp. 494-502
-
-
Kitamoto, T.1
-
100
-
-
84969179560
-
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
-
Zeybel, M. et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin. Epigenetics 7, 25 (2015).
-
(2015)
Clin. Epigenetics
, vol.7
, pp. 25
-
-
Zeybel, M.1
-
101
-
-
78649568544
-
Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter
-
Sookoian, S. et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 52, 1992-2000 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 1992-2000
-
-
Sookoian, S.1
-
102
-
-
84881546730
-
Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
-
Pirola, C. J. et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 62, 1356-1363 (2013).
-
(2013)
Gut
, vol.62
, pp. 1356-1363
-
-
Pirola, C.J.1
-
103
-
-
84908441328
-
Obesity accelerates epigenetic aging of human liver
-
Horvath, S. et al. Obesity accelerates epigenetic aging of human liver. Proc. Natl Acad. Sci. USA 111, 15538-15543 (2014).
-
(2014)
Proc. Natl Acad. Sci. USA
, vol.111
, pp. 15538-15543
-
-
Horvath, S.1
-
104
-
-
84941686246
-
Epigenetic modifications in the biology of nonalcoholic fatty liver disease: The role of DNA hydroxymethylation and TET proteins
-
Pirola, C. J. et al. Epigenetic modifications in the biology of nonalcoholic fatty liver disease: the role of DNA hydroxymethylation and TET proteins. Medicine (Baltimore) 94, e1480 (2015).
-
(2015)
Medicine (Baltimore)
, vol.94
, pp. e1480
-
-
Pirola, C.J.1
-
105
-
-
84868646303
-
Multigenerational epigenetic adaptation of the hepatic wound-healing response
-
Zeybel, M. et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat. Med. 18, 1369-1377 (2012).
-
(2012)
Nat. Med.
, vol.18
, pp. 1369-1377
-
-
Zeybel, M.1
-
106
-
-
84877349202
-
Fetal metabolic programming and epigenetic modifications: A systems biology approach
-
Sookoian, S., Gianotti, T. F., Burgueño, A. L. & Pirola, C. J. Fetal metabolic programming and epigenetic modifications: a systems biology approach. Pediatr. Res. 73, 531-542 (2013).
-
(2013)
Pediatr. Res.
, vol.73
, pp. 531-542
-
-
Sookoian, S.1
Gianotti, T.F.2
Burgueño, A.L.3
Pirola, C.J.4
-
107
-
-
84901045218
-
Maternal diet amplifies the hepatic aging trajectory of Cidea in male mice and leads to the development of fatty liver
-
Carr, S. K. et al. Maternal diet amplifies the hepatic aging trajectory of Cidea in male mice and leads to the development of fatty liver. FASEB J. 28, 2191-2201 (2014).
-
(2014)
FASEB J.
, vol.28
, pp. 2191-2201
-
-
Carr, S.K.1
-
108
-
-
84870316797
-
A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates
-
Suter, M. A. et al. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 26, 5106-5114 (2012).
-
(2012)
FASEB J.
, vol.26
, pp. 5106-5114
-
-
Suter, M.A.1
-
109
-
-
84862795311
-
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
-
Shen, J. et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J. Hepatol. 56, 1363-1370 (2012).
-
(2012)
J. Hepatol.
, vol.56
, pp. 1363-1370
-
-
Shen, J.1
-
110
-
-
84860469242
-
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease
-
Min, H.-K. et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15, 665-674 (2012).
-
(2012)
Cell Metab.
, vol.15
, pp. 665-674
-
-
Min, H.-K.1
-
111
-
-
84928885523
-
Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis
-
Pirola, C. J. et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut 64, 800-812 (2015).
-
(2015)
Gut
, vol.64
, pp. 800-812
-
-
Pirola, C.J.1
-
112
-
-
33645075443
-
MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
-
Esau, C. et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98 (2006).
-
(2006)
Cell Metab.
, vol.3
, pp. 87-98
-
-
Esau, C.1
-
113
-
-
84864761391
-
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
-
Hsu, S.-H. et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122, 2871-2883 (2012).
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 2871-2883
-
-
Hsu, S.-H.1
-
114
-
-
84874109529
-
MiR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
-
Li, J. et al. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J. Hepatol. 58, 522-528 (2013).
-
(2013)
J. Hepatol.
, vol.58
, pp. 522-528
-
-
Li, J.1
-
115
-
-
84921596898
-
MicroRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis
-
Csak, T. et al. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 35, 532-541 (2015).
-
(2015)
Liver Int.
, vol.35
, pp. 532-541
-
-
Csak, T.1
-
116
-
-
84911031215
-
Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis
-
Takaki, Y. et al. Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis. Cancer Sci. 105, 1254-1260 (2014).
-
(2014)
Cancer Sci.
, vol.105
, pp. 1254-1260
-
-
Takaki, Y.1
-
117
-
-
84936846620
-
Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery
-
Wu, Q. et al. Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery. Int. J. Obes. (Lond.) 39, 1126-1134 (2015).
-
(2015)
Int. J. Obes. (Lond.)
, vol.39
, pp. 1126-1134
-
-
Wu, Q.1
-
118
-
-
84881319858
-
DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery
-
Ahrens, M. et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 18, 296-302 (2013).
-
(2013)
Cell Metab.
, vol.18
, pp. 296-302
-
-
Ahrens, M.1
-
119
-
-
84924411357
-
A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice
-
Li, P. et al. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab. 21, 455-467 (2015).
-
(2015)
Cell Metab.
, vol.21
, pp. 455-467
-
-
Li, P.1
-
120
-
-
84904395452
-
Nonalcoholic fatty liver disease and polycystic ovary syndrome
-
Vassilatou, E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J. Gastroenterol. 20, 8351-8363 (2014).
-
(2014)
World J. Gastroenterol.
, vol.20
, pp. 8351-8363
-
-
Vassilatou, E.1
-
121
-
-
79952614750
-
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)
-
Hossain, N. et al. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS). Scand. J. Gastroenterol. 46, 479-484 (2011).
-
(2011)
Scand. J. Gastroenterol.
, vol.46
, pp. 479-484
-
-
Hossain, N.1
-
122
-
-
84896690517
-
Extrahepatic complications of nonalcoholic fatty liver disease
-
Armstrong, M. J., Adams, L. A., Canbay, A. & Syn, W.-K. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59, 1174-1197 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 1174-1197
-
-
Armstrong, M.J.1
Adams, L.A.2
Canbay, A.3
Syn, W.-K.4
-
123
-
-
84901851121
-
Lysosomal acid lipase deficiency - An under-recognized cause of dyslipidaemia and liver dysfunction
-
Reiner, Z. et al. Lysosomal acid lipase deficiency - an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis 235, 21-30 (2014).
-
(2014)
Atherosclerosis
, vol.235
, pp. 21-30
-
-
Reiner, Z.1
-
124
-
-
84877921029
-
Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease
-
Bernstein, D. L., Hülkova, H., Bialer, M. G. & Desnick, R. J. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J. Hepatol. 58, 1230-1243 (2013).
-
(2013)
J. Hepatol.
, vol.58
, pp. 1230-1243
-
-
Bernstein, D.L.1
Hülkova, H.2
Bialer, M.G.3
Desnick, R.J.4
-
125
-
-
77952529040
-
A position statement on NAFLD/ NASH based on the EASL 2009 special conference
-
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/ NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372-384 (2010).
-
(2010)
J. Hepatol.
, vol.53
, pp. 372-384
-
-
Ratziu, V.1
Bellentani, S.2
Cortez-Pinto, H.3
Day, C.4
Marchesini, G.5
-
126
-
-
30944455145
-
Insulin resistance: A metabolic pathway to chronic liver disease
-
Bugianesi, E., McCullough, A. J. & Marchesini, G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42, 987-1000 (2005).
-
(2005)
Hepatology
, vol.42
, pp. 987-1000
-
-
Bugianesi, E.1
McCullough, A.J.2
Marchesini, G.3
-
127
-
-
25144459980
-
The metabolic syndrome - A new worldwide definition
-
IDF Epidemiology Task Force Consensus Group
-
Alberti, K. G., Zimmet, P., Shaw, J. & IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 366, 1059-1062 (2005).
-
(2005)
Lancet
, vol.366
, pp. 1059-1062
-
-
Alberti, K.G.1
Zimmet, P.2
Shaw, J.3
-
128
-
-
33747047274
-
Statins and hepatic steatosis: Perspectives from the Dallas Heart study
-
Browning, J. D. Statins and hepatic steatosis: perspectives from the Dallas Heart study. Hepatology 44, 466-471 (2006).
-
(2006)
Hepatology
, vol.44
, pp. 466-471
-
-
Browning, D.J.1
-
129
-
-
36349033483
-
γ-Glutamyltransferase is associated with incident vascular events independently of alcohol intake: Analysis of the British Women's Heart and Health study and meta-analysis
-
Fraser, A. et al. γ-Glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health study and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 27, 2729-2735 (2007).
-
(2007)
Arterioscler. Thromb. Vasc. Biol.
, vol.27
, pp. 2729-2735
-
-
Fraser, A.1
-
130
-
-
1442281989
-
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
-
Bugianesi, E. et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39, 179-187 (2004).
-
(2004)
Hepatology
, vol.39
, pp. 179-187
-
-
Bugianesi, E.1
-
131
-
-
77956639983
-
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
-
Neuschwander-Tetri, B. A. et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52, 913-924 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 913-924
-
-
Neuschwander-Tetri, B.A.1
-
132
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
-
133
-
-
84892649479
-
Standards of medical care in diabetes - 2014
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 37, S14-S80 (2014).
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
-
134
-
-
77958154016
-
Controlled attenuation parameter (CAP): A novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes
-
Sasso, M. et al. Controlled attenuation parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med. Biol. 36, 1825-1835 (2010).
-
(2010)
Ultrasound Med. Biol.
, vol.36
, pp. 1825-1835
-
-
Sasso, M.1
-
135
-
-
84904346796
-
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease
-
Chan, W.-K., Nik Mustapha, N. R. & Mahadeva, S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 29, 1470-1476 (2014).
-
(2014)
J. Gastroenterol. Hepatol.
, vol.29
, pp. 1470-1476
-
-
Chan, W.-K.1
Nik Mustapha, N.R.2
Mahadeva, S.3
-
136
-
-
84861961483
-
Controlled attenuation parameter (CAP): A noninvasive method for the detection of hepatic steatosis based on transient elastography
-
Myers, R. P. et al. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 32, 902-910 (2012).
-
(2012)
Liver Int.
, vol.32
, pp. 902-910
-
-
Myers, R.P.1
-
137
-
-
84898640575
-
Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy
-
Karlas, T. et al. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS ONE 9, e91987 (2014).
-
(2014)
PLoS ONE
, vol.9
, pp. e91987
-
-
Karlas, T.1
-
138
-
-
84867834721
-
Proton density fat-fraction: A standardized MR-based biomarker of tissue fat concentration
-
Reeder, S. B., Hu, H. H. & Sirlin, C. B. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J. Magn. Reson. Imaging 36, 1011-1014 (2012).
-
(2012)
J. Magn. Reson. Imaging
, vol.36
, pp. 1011-1014
-
-
Reeder, S.B.1
Hu, H.H.2
Sirlin, C.B.3
-
139
-
-
84921785945
-
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease
-
Tang, A. et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274, 416-425 (2015).
-
(2015)
Radiology
, vol.274
, pp. 416-425
-
-
Tang, A.1
-
140
-
-
84876907610
-
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
-
Tang, A. et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267, 422-431 (2013).
-
(2013)
Radiology
, vol.267
, pp. 422-431
-
-
Tang, A.1
-
141
-
-
84929607638
-
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease
-
Schwimmer, J. B. et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61, 1887-1895 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 1887-1895
-
-
Schwimmer, J.B.1
-
142
-
-
85027925485
-
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
-
Permutt, Z. et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment. Pharmacol. Ther. 36, 22-29 (2012).
-
(2012)
Aliment. Pharmacol. Ther.
, vol.36
, pp. 22-29
-
-
Permutt, Z.1
-
143
-
-
84939255323
-
Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects
-
Artz, N. S. et al. Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects. J. Magn. Reson. Imaging 42, 811-817 (2015).
-
(2015)
J. Magn. Reson. Imaging
, vol.42
, pp. 811-817
-
-
Artz, N.S.1
-
144
-
-
79953246982
-
T1 independent, T2∗corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis
-
Hines, C. D. G. et al. T1 independent, T2∗corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J. Magn. Reson. Imaging 33, 873-881 (2011).
-
(2011)
J. Magn. Reson. Imaging
, vol.33
, pp. 873-881
-
-
Hines, C.D.G.1
-
145
-
-
84855484110
-
Robustness of fat quantification using chemical shift imaging
-
Hansen, K. H., Schroeder, M. E., Hamilton, G., Sirlin, C. B. & Bydder, M. Robustness of fat quantification using chemical shift imaging. Magn. Reson. Imaging 30, 151-157 (2012).
-
(2012)
Magn. Reson. Imaging
, vol.30
, pp. 151-157
-
-
Hansen, K.H.1
Schroeder, M.E.2
Hamilton, G.3
Sirlin, C.B.4
Bydder, M.5
-
146
-
-
84857944399
-
Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research
-
Kleiner, D. E. & Brunt, E. M. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin. Liver Dis. 32, 3-13 (2012).
-
(2012)
Semin. Liver Dis.
, vol.32
, pp. 3-13
-
-
Kleiner, D.E.1
Brunt, E.M.2
-
147
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923 (2003).
-
(2003)
Hepatology
, vol.37
, pp. 917-923
-
-
Marchesini, G.1
-
148
-
-
84931572246
-
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63, 237-264 (2015).
-
(2015)
J. Hepatol.
, vol.63
, pp. 237-264
-
-
-
149
-
-
84908467011
-
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
-
Fedchuk, L. et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 40, 1209-1222 (2014).
-
(2014)
Aliment. Pharmacol. Ther.
, vol.40
, pp. 1209-1222
-
-
Fedchuk, L.1
-
150
-
-
84887321522
-
Noninvasive evaluation of NAFLD
-
Castera, L., Vilgrain, V. & Angulo, P. Noninvasive evaluation of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 666-675 (2013).
-
(2013)
Nat. Rev. Gastroenterol. Hepatol.
, vol.10
, pp. 666-675
-
-
Castera, L.1
Vilgrain, V.2
Angulo, P.3
-
151
-
-
84891889855
-
Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease - The role of transient elastography and plasma cytokeratin-18 fragments
-
Kwok, R. et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments. Aliment. Pharmacol. Ther. 39, 254-269 (2014).
-
(2014)
Aliment. Pharmacol. Ther.
, vol.39
, pp. 254-269
-
-
Kwok, R.1
-
152
-
-
84876293750
-
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
-
Machado, M. V. & Cortez-Pinto, H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J. Hepatol. 58, 1007-1019 (2013).
-
(2013)
J. Hepatol.
, vol.58
, pp. 1007-1019
-
-
Machado, M.V.1
Cortez-Pinto, H.2
-
153
-
-
84899089918
-
Evidence and recommendations for imaging liver fat in children, based on systematic review
-
Awai, H. I., Newton, K. P., Sirlin, C. B., Behling, C. & Schwimmer, J. B. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin. Gastroenterol. Hepatol. 12, 765-773 (2014).
-
(2014)
Clin. Gastroenterol. Hepatol.
, vol.12
, pp. 765-773
-
-
Awai, H.I.1
Newton, K.P.2
Sirlin, C.B.3
Behling, C.4
Schwimmer, J.B.5
-
154
-
-
84938539553
-
Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniques
-
Tang, A., Cloutier, G., Szeverenyi, N. M. & Sirlin, C. B. Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques. AJR Am. J. Roentgenol. 205, 22-32 (2015).
-
(2015)
AJR Am. J. Roentgenol.
, vol.205
, pp. 22-32
-
-
Tang, A.1
Cloutier, G.2
Szeverenyi, N.M.3
Sirlin, C.B.4
-
155
-
-
9144249563
-
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis
-
Sandrin, L. et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 29, 1705-1713 (2003).
-
(2003)
Ultrasound Med. Biol.
, vol.29
, pp. 1705-1713
-
-
Sandrin, L.1
-
156
-
-
84876116484
-
EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology
-
Bamber, J. et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology. Ultraschall Med. 34, 169-184 (2013).
-
(2013)
Ultraschall Med.
, vol.34
, pp. 169-184
-
-
Bamber, J.1
-
157
-
-
84927566853
-
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: Liver
-
Ferraioli, G. et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver. Ultrasound Med. Biol. 41, 1161-1179 (2015).
-
(2015)
Ultrasound Med. Biol.
, vol.41
, pp. 1161-1179
-
-
Ferraioli, G.1
-
158
-
-
84155188892
-
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
-
Myers, R. P. et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55, 199-208 (2012).
-
(2012)
Hepatology
, vol.55
, pp. 199-208
-
-
Myers, R.P.1
-
159
-
-
84881552256
-
Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
-
Bota, S. et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 33, 1138-1147 (2013).
-
(2013)
Liver Int.
, vol.33
, pp. 1138-1147
-
-
Bota, S.1
-
160
-
-
84856968669
-
Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
-
Friedrich-Rust, M. et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur. J. Radiol. 81, e325-e331 (2012).
-
(2012)
Eur. J. Radiol.
, vol.81
, pp. e325-e331
-
-
Friedrich-Rust, M.1
-
161
-
-
0029654138
-
Magnetic resonance elastography by direct visualization of propagating acoustic strain waves
-
Muthupillai, R. et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269, 1854-1857 (1995).
-
(1995)
Science
, vol.269
, pp. 1854-1857
-
-
Muthupillai, R.1
-
162
-
-
84874226671
-
Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
-
Venkatesh, S. K., Yin, M. & Ehman, R. L. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J. Magn. Reson. Imaging 37, 544-555 (2013).
-
(2013)
J. Magn. Reson. Imaging
, vol.37
, pp. 544-555
-
-
Venkatesh, S.K.1
Yin, M.2
Ehman, R.L.3
-
163
-
-
84939952892
-
Cross-vendor validation of liver magnetic resonance elastography
-
Serai, S. D., Yin, M., Wang, H., Ehman, R. L. & Podberesky, D. J. Cross-vendor validation of liver magnetic resonance elastography. Abdom. Imaging 40, 789-794 (2014).
-
(2014)
Abdom. Imaging
, vol.40
, pp. 789-794
-
-
Serai, S.D.1
Yin, M.2
Wang, H.3
Ehman, R.L.4
Podberesky, D.J.5
-
164
-
-
84880649809
-
Advanced fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment with MR elastography
-
Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J. & Ehman, R. L. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 268, 411-419 (2013).
-
(2013)
Radiology
, vol.268
, pp. 411-419
-
-
Kim, D.1
Kim, W.R.2
Talwalkar, J.A.3
Kim, H.J.4
Ehman, R.L.5
-
165
-
-
84911948591
-
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
-
Loomba, R. et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 60, 1920-1928 (2014).
-
(2014)
Hepatology
, vol.60
, pp. 1920-1928
-
-
Loomba, R.1
-
166
-
-
84937522314
-
Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis
-
Arulanandan, A. et al. Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 13, 1513-1520 (2015).
-
(2015)
Clin. Gastroenterol. Hepatol.
, vol.13
, pp. 1513-1520
-
-
Arulanandan, A.1
-
167
-
-
84926420209
-
Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis
-
Ichikawa, S. et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn. Reson. Imaging 33, 26-30 (2015).
-
(2015)
Magn. Reson. Imaging
, vol.33
, pp. 26-30
-
-
Ichikawa, S.1
-
168
-
-
70349765667
-
Lifestyle modification as the primary treatment of NASH
-
Neuschwander-Tetri, B. A. Lifestyle modification as the primary treatment of NASH. Clin. Liver Dis. 13, 649-665 (2009).
-
(2009)
Clin. Liver Dis.
, vol.13
, pp. 649-665
-
-
Neuschwander-Tetri, B.A.1
-
169
-
-
77954235797
-
Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease
-
Johnson, N. A. & George, J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 52, 370-381 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 370-381
-
-
Johnson, N.A.1
George, J.2
-
170
-
-
84929354082
-
Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
-
Vilar-Gomez, E. et al. Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367-378 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 367-378
-
-
Vilar-Gomez, E.1
-
171
-
-
39549092421
-
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
-
Bellentani, S., Dalle Grave, R., Suppini, A. & Marchesini, G. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 47, 746-754 (2008).
-
(2008)
Hepatology
, vol.47
, pp. 746-754
-
-
Bellentani, S.1
Dalle Grave, R.2
Suppini, A.3
Marchesini, G.4
-
172
-
-
77952574249
-
The effect of lifestyle changes in non-alcoholic fatty liver disease
-
Centis, E., Marzocchi, R., Di Domizio, S., Ciaravella, M. F. & Marchesini, G. The effect of lifestyle changes in non-alcoholic fatty liver disease. Dig. Dis. 28, 267-273 (2010).
-
(2010)
Dig. Dis.
, vol.28
, pp. 267-273
-
-
Centis, E.1
Marzocchi, R.2
Di Domizio, S.3
Ciaravella, M.F.4
Marchesini, G.5
-
173
-
-
70349771924
-
Non-alcoholic fatty liver disease: Is bariatric surgery the answer?
-
Pillai, A. A. & Rinella, M. E. Non-alcoholic fatty liver disease: is bariatric surgery the answer? Clin. Liver Dis. 13, 689-710 (2009).
-
(2009)
Clin. Liver Dis.
, vol.13
, pp. 689-710
-
-
Pillai, A.A.1
Rinella, M.E.2
-
174
-
-
84938070225
-
Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients
-
Lassailly, G. et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149, 379-388 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 379-388
-
-
Lassailly, G.1
-
175
-
-
77955690182
-
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
-
Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
176
-
-
84859404868
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications
-
Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142, 711-725 (2012).
-
(2012)
Gastroenterology
, vol.142
, pp. 711-725
-
-
Cusi, K.1
-
177
-
-
83555176010
-
Lipotoxicity in NASH
-
Fuchs, M. & Sanyal, A. J. Lipotoxicity in NASH. J. Hepatol. 56, 291-293 (2012).
-
(2012)
J. Hepatol.
, vol.56
, pp. 291-293
-
-
Fuchs, M.1
Sanyal, A.J.2
-
178
-
-
84919800440
-
Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity
-
Bouret, S., Levin, B. E. & Ozanne, S. E. Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity. Physiol. Rev. 95, 47-82 (2015).
-
(2015)
Physiol. Rev.
, vol.95
, pp. 47-82
-
-
Bouret, S.1
Levin, B.E.2
Ozanne, S.E.3
-
179
-
-
19944431011
-
Cardiovascular risk factors emerge after artificial selection for low aerobic capacity
-
Wisløff, U. et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307, 418-420 (2005).
-
(2005)
Science
, vol.307
, pp. 418-420
-
-
Wisløff, U.1
-
180
-
-
84920627180
-
Activation of human brown adipose tissue by a β3-adrenergic receptor agonist
-
Cypess, A. M. et al. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metab. 21, 33-38 (2015).
-
(2015)
Cell Metab.
, vol.21
, pp. 33-38
-
-
Cypess, A.M.1
-
181
-
-
84923212941
-
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis
-
Crane, J. D. et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 21, 166-172 (2014).
-
(2014)
Nat. Med.
, vol.21
, pp. 166-172
-
-
Crane, J.D.1
-
182
-
-
34547472174
-
Food energy efficiency, cannabinoids, and a slow death of the weight loss dogma
-
Neuschwander-Tetri, B. A. Food energy efficiency, cannabinoids, and a slow death of the weight loss dogma. Hepatology 46, 12-15 (2007).
-
(2007)
Hepatology
, vol.46
, pp. 12-15
-
-
Neuschwander-Tetri, B.A.1
-
183
-
-
33645983221
-
LXRS and FXR: The Yin and Yang of cholesterol and fat metabolism
-
Kalaany, N. Y. & Mangelsdorf, D. J. LXRS and FXR: the Yin and Yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68, 159-191 (2006).
-
(2006)
Annu. Rev. Physiol.
, vol.68
, pp. 159-191
-
-
Kalaany, N.Y.1
Mangelsdorf, D.J.2
-
184
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
-
Neuschwander-Tetri, B. A. et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385, 956-965 (2015).
-
(2015)
Lancet
, vol.385
, pp. 956-965
-
-
Neuschwander-Tetri, B.A.1
-
185
-
-
84859942552
-
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
-
Lomonaco, R. et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55, 1389-1397 (2012).
-
(2012)
Hepatology
, vol.55
, pp. 1389-1397
-
-
Lomonaco, R.1
-
186
-
-
70350064027
-
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
-
Gastaldelli, A. et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50, 1087-1093 (2009).
-
(2009)
Hepatology
, vol.50
, pp. 1087-1093
-
-
Gastaldelli, A.1
-
187
-
-
77951874018
-
Pioglitazone Vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal, A. & Chalasani, N. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362,1675-1685 (2010).
-
(2010)
N. Engl. J. Med.
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.1
Chalasani, N.2
-
188
-
-
79955446251
-
Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial
-
Lavine, J. E. et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305, 1659-1668 (2011).
-
(2011)
JAMA
, vol.305
, pp. 1659-1668
-
-
Lavine, J.E.1
-
189
-
-
84895068880
-
Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): When to use metformin in nonalcoholic fatty liver disease (NAFLD)
-
Doycheva, I. & Loomba, R. Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). Adv. Ther. 31, 30-43 (2014).
-
(2014)
Adv. Ther.
, vol.31
, pp. 30-43
-
-
Doycheva, I.1
Loomba, R.2
-
190
-
-
79960988152
-
Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism
-
Cariou, B., Zaïr, Y., Staels, B. & Bruckert, E. Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism. Diabetes Care 34, 2008-2014 (2011).
-
(2011)
Diabetes Care
, vol.34
, pp. 2008-2014
-
-
Cariou, B.1
Zaïr, Y.2
Staels, B.3
Bruckert, E.4
-
191
-
-
84655169624
-
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
-
Rolo, A. P., Teodoro, J. S. & Palmeira, C. M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 52, 59-69 (2012).
-
(2012)
Free Radic. Biol. Med.
, vol.52
, pp. 59-69
-
-
Rolo, A.P.1
Teodoro, J.S.2
Palmeira, C.M.3
-
192
-
-
34548804940
-
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: Possible role of Vitamin A intake
-
Musso, G. et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am. J. Clin. Nutr. 86, 661-671 (2007).
-
(2007)
Am. J. Clin. Nutr.
, vol.86
, pp. 661-671
-
-
Musso, G.1
-
193
-
-
84879242918
-
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
-
Hoofnagle, J. H. et al. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 38, 134-143 (2013).
-
(2013)
Aliment. Pharmacol. Ther.
, vol.38
, pp. 134-143
-
-
Hoofnagle, J.H.1
-
194
-
-
84904661185
-
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a Phase 2 trial
-
Sanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W. & Chojkier, M. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a Phase 2 trial. Gastroenterology 147, 377-384 (2014).
-
(2014)
Gastroenterology
, vol.147
, pp. 377-384
-
-
Sanyal, A.J.1
Abdelmalek, M.F.2
Suzuki, A.3
Cummings, O.W.4
Chojkier, M.5
-
195
-
-
84875143788
-
Targeting endoplasmic reticulum stress in metabolic disease
-
Cao, S. S. & Kaufman, R. J. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin. Ther. Targets 17, 437-448 (2013).
-
(2013)
Expert Opin. Ther. Targets
, vol.17
, pp. 437-448
-
-
Cao, S.S.1
Kaufman, R.J.2
-
196
-
-
84876803994
-
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
-
Ioannou, G. N., Haigh, W. G., Thorning, D. & Savard, C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J. Lipid Res. 54, 1326-1334 (2013).
-
(2013)
J. Lipid Res.
, vol.54
, pp. 1326-1334
-
-
Ioannou, G.N.1
Haigh, W.G.2
Thorning, D.3
Savard, C.4
-
197
-
-
84899810207
-
The national lipid association's statin safety task force. An assessment by the statin liver safety task force: 2014 update
-
Bays, H., Cohen, D. E., Chalasani, N., Harrison, S. A. & The National Lipid Association's Statin Safety Task Force. An assessment by the Statin Liver Safety Task Force: 2014 update. J. Clin. Lipidol. 8, S47-S57 (2014).
-
(2014)
J. Clin. Lipidol.
, vol.8
, pp. S47-S57
-
-
Bays, H.1
Cohen, D.E.2
Chalasani, N.3
Harrison, S.A.4
-
198
-
-
84897368255
-
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
-
Eslami, L., Merat, S., Malekzadeh, R., Nasseri-Moghaddam, S. & Aramin, H. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Cochrane Database Syst. Rev. 12, CD008623 (2013).
-
(2013)
Cochrane Database Syst. Rev.
, vol.12
, pp. CD008623
-
-
Eslami, L.1
Merat, S.2
Malekzadeh, R.3
Nasseri-Moghaddam, S.4
Aramin, H.5
-
199
-
-
84939268765
-
Statin use and non-alcoholic steatohepatitis in at risk individuals
-
Dongiovanni, P. et al. Statin use and non-alcoholic steatohepatitis in at risk individuals. J. Hepatol. 63, 705-712 (2015).
-
(2015)
J. Hepatol.
, vol.63
, pp. 705-712
-
-
Dongiovanni, P.1
-
200
-
-
84908090042
-
Lack of efficacy of an inhibitor of PDE4 in Phase 1 and 2 trials of patients with nonalcoholic steatohepatitis
-
Ratziu, V. et al. Lack of efficacy of an inhibitor of PDE4 in Phase 1 and 2 trials of patients with nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 12, 1724-1730 (2014).
-
(2014)
Clin. Gastroenterol. Hepatol.
, vol.12
, pp. 1724-1730
-
-
Ratziu, V.1
-
201
-
-
84856400671
-
A Phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
-
Ratziu, V. et al. A Phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology 55, 419-428 (2012).
-
(2012)
Hepatology
, vol.55
, pp. 419-428
-
-
Ratziu, V.1
-
202
-
-
34548359121
-
Health-related quality of life in patients with non-alcoholic fatty liver disease
-
Dan, A. A. et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 26, 815-820 (2007).
-
(2007)
Aliment. Pharmacol. Ther.
, vol.26
, pp. 815-820
-
-
Dan, A.A.1
-
203
-
-
68249122450
-
Predictors of health-related quality of life in patients with chronic liver disease
-
Afendy, A. et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment. Pharmacol. Ther. 30, 469-476 (2009).
-
(2009)
Aliment. Pharmacol. Ther.
, vol.30
, pp. 469-476
-
-
Afendy, A.1
-
204
-
-
1242340436
-
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
-
Hickman, I. J. et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 53, 413-419 (2004).
-
(2004)
Gut
, vol.53
, pp. 413-419
-
-
Hickman, I.J.1
-
205
-
-
68949136754
-
Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network
-
David, K. et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49, 1904-1912 (2009).
-
(2009)
Hepatology
, vol.49
, pp. 1904-1912
-
-
David, K.1
-
206
-
-
34548087021
-
The missing link - Lose weight, live longer
-
Bray, G. A. The missing link - lose weight, live longer. N. Engl. J. Med. 357, 818-820 (2007).
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 818-820
-
-
Bray, G.A.1
-
207
-
-
34548090763
-
Effects of bariatric surgery on mortality in Swedish obese subjects
-
Sjöström, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741-752 (2007).
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 741-752
-
-
Sjöström, L.1
-
208
-
-
34548075820
-
Long-term mortality after gastric bypass surgery
-
Adams, T. D. et al. Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 357, 753-761 (2007).
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 753-761
-
-
Adams, T.D.1
-
209
-
-
10844295087
-
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
-
Sjöström, L. et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N. Engl. J. Med. 351, 2683-2693 (2004).
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 2683-2693
-
-
Sjöström, L.1
-
210
-
-
84960917463
-
The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones
-
Meek, C. L., Lewis, H. B., Reimann, F., Gribble, F. M. & Park, A. J. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides http://dx.doi.org/10.1016/ j.peptides.2015.08.013 (2015).
-
(2015)
Peptides
-
-
Meek, C.L.1
Lewis, H.B.2
Reimann, F.3
Gribble, F.M.4
Park, A.J.5
-
211
-
-
84898051705
-
FXR is a molecular target for the effects of vertical sleeve gastrectomy
-
Ryan, K. K. et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509, 183-188 (2014).
-
(2014)
Nature
, vol.509
, pp. 183-188
-
-
Ryan, K.K.1
-
212
-
-
84898030895
-
FXR: The key to benefits in bariatric surgery?
-
Kuipers, F. & Groen, A. K. FXR: the key to benefits in bariatric surgery? Nat. Med. 20, 337-338 (2014).
-
(2014)
Nat. Med.
, vol.20
, pp. 337-338
-
-
Kuipers, F.1
Groen, A.K.2
-
213
-
-
77954974824
-
Hospital complication rates with bariatric surgery in Michigan
-
Birkmeyer, N. J. O. et al. Hospital complication rates with bariatric surgery in Michigan. JAMA 304, 435-442 (2010).
-
(2010)
JAMA
, vol.304
, pp. 435-442
-
-
Birkmeyer, N.J.O.1
-
214
-
-
84939418154
-
Systematic review of bariatric surgery in patients with liver cirrhosis
-
Jan, A., Narwaria, M. & Mahawar, K. K. A. Systematic review of bariatric surgery in patients with liver cirrhosis. Obes. Surg. 25, 1518-1526 (2015).
-
(2015)
Obes. Surg.
, vol.25
, pp. 1518-1526
-
-
Jan, A.1
Narwaria, M.2
Mahawar, K.K.A.3
-
215
-
-
84862908535
-
Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008
-
Yang, J. D. et al. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin. Proc. 87, 9-16 (2012).
-
(2012)
Mayo Clin. Proc.
, vol.87
, pp. 9-16
-
-
Yang, J.D.1
-
216
-
-
67649313330
-
Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma
-
Malik, S. M., Gupte, P. A., de Vera, M. E. & Ahmad, J. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 7, 800-806 (2009).
-
(2009)
Clin. Gastroenterol. Hepatol.
, vol.7
, pp. 800-806
-
-
Malik, S.M.1
Gupte, P.A.2
De Vera, M.E.3
Ahmad, J.4
-
217
-
-
84955213803
-
Association of non-alcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004-2009
-
Younossi, Z. M. et al. Association of non-alcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004-2009. Hepatology http://dx.doi.org/10.1002/hep.28123 (2015).
-
(2015)
Hepatology
-
-
Younossi, Z.M.1
-
218
-
-
84881171445
-
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States
-
Welzel, T. M. et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am. J. Gastroenterol. 108, 1314-1321 (2013).
-
(2013)
Am. J. Gastroenterol.
, vol.108
, pp. 1314-1321
-
-
Welzel, T.M.1
-
219
-
-
84901616858
-
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U. S
-
Wong, R. J., Cheung, R. & Ahmed, A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U. S. Hepatology 59, 2188-2195 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 2188-2195
-
-
Wong, R.J.1
Cheung, R.2
Ahmed, A.3
-
220
-
-
0030774675
-
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
-
Wideroff, L. et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl Cancer Inst. 89, 1360-1365 (1997).
-
(1997)
J. Natl Cancer Inst.
, vol.89
, pp. 1360-1365
-
-
Wideroff, L.1
-
221
-
-
79955033727
-
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
-
Yasui, K. et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 9, 428-433 (2011).
-
(2011)
Clin. Gastroenterol. Hepatol.
, vol.9
, pp. 428-433
-
-
Yasui, K.1
-
222
-
-
84879925475
-
Epidemiology of hepatocellular carcinoma: Consider the population
-
Mittal, S. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma: consider the population. J. Clin. Gastroenterol. 47, S2-S6 (2013).
-
(2013)
J. Clin. Gastroenterol.
, vol.47
, pp. S2-S6
-
-
Mittal, S.1
El-Serag, H.B.2
-
223
-
-
84937576853
-
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
-
Jiang, W. et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep. 5, 8096 (2015).
-
(2015)
Sci. Rep.
, vol.5
, pp. 8096
-
-
Jiang, W.1
-
224
-
-
84887318014
-
The Gordian Knot of dysbiosis, obesity and NAFLD
-
Mehal, W. Z. The Gordian Knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 637-644 (2013).
-
(2013)
Nat. Rev. Gastroenterol. Hepatol.
, vol.10
, pp. 637-644
-
-
Mehal, W.Z.1
-
225
-
-
84872161044
-
The gut microbiota, obesity and insulin resistance
-
Shen, J., Obin, M. S. & Zhao, L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34, 39-58 (2013).
-
(2013)
Mol. Aspects Med.
, vol.34
, pp. 39-58
-
-
Shen, J.1
Obin, M.S.2
Zhao, L.3
-
226
-
-
84923849535
-
Implication of gut microbiota in nonalcoholic fatty liver disease
-
Boursier, J. & Diehl, A. M. Implication of gut microbiota in nonalcoholic fatty liver disease. PLoS Pathog. 11, e1004559 (2015).
-
(2015)
PLoS Pathog.
, vol.11
, pp. e1004559
-
-
Boursier, J.1
Diehl, A.M.2
-
227
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005).
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
-
228
-
-
84868235041
-
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
-
Bedossa, P. et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56, 1751-1759 (2012).
-
(2012)
Hepatology
, vol.56
, pp. 1751-1759
-
-
Bedossa, P.1
-
229
-
-
67349256422
-
Retinol-binding protein 4: A promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease
-
Nobili, V. et al. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 575-579 (2009).
-
(2009)
Clin. Gastroenterol. Hepatol.
, vol.7
, pp. 575-579
-
-
Nobili, V.1
-
230
-
-
53849114643
-
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)
-
Younossi, Z. M. et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes. Surg. 18, 1430-1437 (2008).
-
(2008)
Obes. Surg.
, vol.18
, pp. 1430-1437
-
-
Younossi, Z.M.1
-
231
-
-
33646013904
-
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease
-
Palekar, N. A., Naus, R., Larson, S. P., Ward, J. & Harrison, S. A. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int. 26, 151-156 (2006).
-
(2006)
Liver Int.
, vol.26
, pp. 151-156
-
-
Palekar, N.A.1
Naus, R.2
Larson, S.P.3
Ward, J.4
Harrison, S.A.5
-
232
-
-
52649112178
-
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
-
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S. & Neuschwander-Tetri, B. A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57, 1441-1447 (2008).
-
(2008)
Gut
, vol.57
, pp. 1441-1447
-
-
Harrison, S.A.1
Oliver, D.2
Arnold, H.L.3
Gogia, S.4
Neuschwander-Tetri, B.A.5
-
233
-
-
0034116558
-
Liver fibrosis in overweight patients
-
Ratziu, V. et al. Liver fibrosis in overweight patients. Gastroenterology 118, 1117-1123 (2000).
-
(2000)
Gastroenterology
, vol.118
, pp. 1117-1123
-
-
Ratziu, V.1
-
234
-
-
77952680758
-
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart study
-
Speliotes, E. K. et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart study. Hepatology 51, 1979-1987 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1979-1987
-
-
Speliotes, E.K.1
-
235
-
-
2942737189
-
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation
-
Hwang, S. et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl. 10, 721-725 (2004).
-
(2004)
Liver Transpl.
, vol.10
, pp. 721-725
-
-
Hwang, S.1
-
236
-
-
84876040518
-
Non-alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study
-
Malik, A., Cheah, P.-L., Hilmi, I. N., Chan, S. P. & Goh, K.-L. Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study. J. Dig. Dis. 8, 58-64 (2007).
-
(2007)
J. Dig. Dis.
, vol.8
, pp. 58-64
-
-
Malik, A.1
Cheah, P.-L.2
Hilmi, I.N.3
Chan, S.P.4
Goh, K.-L.5
-
237
-
-
28044446543
-
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
-
Hamaguchi, M. et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 143, 722-728 (2005).
-
(2005)
Ann. Intern. Med.
, vol.143
, pp. 722-728
-
-
Hamaguchi, M.1
-
238
-
-
23444451889
-
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
-
Fan, J.-G. et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 43, 508-514 (2005).
-
(2005)
J. Hepatol.
, vol.43
, pp. 508-514
-
-
Fan, J.-G.1
-
239
-
-
77951493150
-
Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
-
Das, K. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 51, 1593-1602 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 1593-1602
-
-
Das, K.1
-
240
-
-
84870855668
-
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults
-
Kwon, Y.-M. et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 107, 1852-1858 (2012).
-
(2012)
Am. J. Gastroenterol.
, vol.107
, pp. 1852-1858
-
-
Kwon, Y.-M.1
-
241
-
-
0026640577
-
Fatty infiltration of the liver: Analysis of prevalence, radiological and clinical features and influence on patient management
-
el-Hassan, A. Y., Ibrahim, E. M., al-Mulhim, F. A., Nabhan, A. A. & Chammas, M. Y. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br. J. Radiol. 65, 774-778 (1992).
-
(1992)
Br. J. Radiol.
, vol.65
, pp. 774-778
-
-
El-Hassan, A.Y.1
Ibrahim, E.M.2
Al-Mulhim, F.A.3
Nabhan, A.A.4
Chammas, M.Y.5
-
242
-
-
84876821330
-
A retrospective evaluation of causes of exempting living liver donors in an Egyptian centre
-
Aboueisha, H. et al. A retrospective evaluation of causes of exempting living liver donors in an Egyptian centre. Arab J. Gastroenterol. 14, 10-13 (2013).
-
(2013)
Arab J. Gastroenterol.
, vol.14
, pp. 10-13
-
-
Aboueisha, H.1
-
243
-
-
0034089687
-
Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents
-
Strauss, R. S., Barlow, S. E. & Dietz, W. H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J. Pediatr. 136, 727-733 (2000).
-
(2000)
J. Pediatr.
, vol.136
, pp. 727-733
-
-
Strauss, R.S.1
Barlow, S.E.2
Dietz, W.H.3
-
244
-
-
27744452634
-
Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children
-
Zou, C. C., Liang, L., Hong, F., Fu, J. F. & Zhao, Z. Y. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr. J. 52, 519-524 (2005).
-
(2005)
Endocr. J.
, vol.52
, pp. 519-524
-
-
Zou, C.C.1
Liang, L.2
Hong, F.3
Fu, J.F.4
Zhao, Z.Y.5
-
245
-
-
0034078045
-
Liver steatosis in juvenile obesity: Correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test
-
Guzzaloni, G., Grugni, G., Minocci, A., Moro, D. & Morabito, F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int. J. Obes. Relat. Metab. Disord. 24, 772-776 (2000).
-
(2000)
Int. J. Obes. Relat. Metab. Disord.
, vol.24
, pp. 772-776
-
-
Guzzaloni, G.1
Grugni, G.2
Minocci, A.3
Moro, D.4
Morabito, F.5
-
246
-
-
34447644518
-
Nonalcoholic steatohepatitis in obese children: The prevalence and possible mechanism
-
in Chinese
-
Fu, J. et al. Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism. Zhejiang Da Xue Xue Bao Yi Xue Ban 35, 64-68 (in Chinese) (2006).
-
(2006)
Zhejiang da Xue Xue Bao Yi Xue Ban
, vol.35
, pp. 64-68
-
-
Fu, J.1
-
247
-
-
0242361733
-
Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
-
Schwimmer, J. B. et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J. Pediatr. 143, 500-505 (2003).
-
(2003)
J. Pediatr.
, vol.143
, pp. 500-505
-
-
Schwimmer, J.B.1
-
248
-
-
33747077203
-
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
-
Nobili, V. et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44, 458-465 (2006).
-
(2006)
Hepatology
, vol.44
, pp. 458-465
-
-
Nobili, V.1
-
249
-
-
70350241227
-
The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years
-
Feldstein, A. E. et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58, 1538-1544 (2009).
-
(2009)
Gut
, vol.58
, pp. 1538-1544
-
-
Feldstein, A.E.1
-
250
-
-
33751246499
-
The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population
-
Bedogni, G. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).
-
(2006)
BMC Gastroenterol.
, vol.6
, pp. 33
-
-
Bedogni, G.1
-
251
-
-
69249087403
-
Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors
-
Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137, 865-872 (2009).
-
(2009)
Gastroenterology
, vol.137
, pp. 865-872
-
-
Kotronen, A.1
-
252
-
-
84858224449
-
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: Meta analysis of individual patient data
-
Poynard, T. et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS ONE 7, e30325 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e30325
-
-
Poynard, T.1
-
253
-
-
34247384560
-
The NAFLD Fibrosis Score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
-
Angulo, P. et al. The NAFLD Fibrosis Score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846-854 (2007).
-
(2007)
Hepatology
, vol.45
, pp. 846-854
-
-
Angulo, P.1
-
254
-
-
33644607568
-
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
-
Ratziu, V. et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 6, 6 (2006).
-
(2006)
BMC Gastroenterol.
, vol.6
, pp. 6
-
-
Ratziu, V.1
-
255
-
-
70349546276
-
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
-
Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 1104-1112 (2009).
-
(2009)
Clin. Gastroenterol. Hepatol.
, vol.7
, pp. 1104-1112
-
-
Shah, A.G.1
-
256
-
-
80053095798
-
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease
-
Adams, L. A. et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 26, 1536-1543 (2011).
-
(2011)
J. Gastroenterol. Hepatol.
, vol.26
, pp. 1536-1543
-
-
Adams, L.A.1
-
257
-
-
39549118158
-
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
-
Guha, I. N. et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47, 455-460 (2008).
-
(2008)
Hepatology
, vol.47
, pp. 455-460
-
-
Guha, I.N.1
|